歡迎來到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當(dāng)前位置: 首頁(yè) > 科研產(chǎn)品 > 科研抗體 > 一抗 > 兔抗MCFD2多克隆抗體

產(chǎn)品中心

  • 兔抗MCFD2多克隆抗體

    規(guī)格:
    數(shù)量:

    購(gòu)買數(shù)量

    價(jià)格:
    • 品牌 : 通蔚生物
    • 目錄號(hào) : TW18161
    • 應(yīng)用 : 僅供科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫(kù)存:80
  • 商品詳情
  • 參考文獻(xiàn)
  • 說明書下載
  • 商品評(píng)論0
  • 相關(guān)產(chǎn)品

中文名稱 :    兔抗MCFD2多克隆抗體


英文名稱 :    Anti-MCFD2 rabbit polyclonal antibody


別       名 :    multiple coagulation factor deficiency 2; F5F8D; SDNSF; F5F8D2; LMAN1IP


相關(guān)類別 :   一抗


抗       原 :   MCFD2


儲(chǔ)      存 :   冷凍(-20℃)


宿      主 :   Rabbit


反應(yīng)種屬 :   Human, Mouse, Rat


標(biāo)  記 物 :    Unconjugate


克隆類型 :   rabbit polyclonal


技術(shù)規(guī)格

Background:

This gene encodes a soluble luminal protein with two calmodulin-like EF-hand motifs at its C-terminus. This protein forms a complex with LMAN1 (lectin mannose binding protein 1; also known as ERGIC-53) that facilitates the transport of coagulation factors V (FV) and VIII (FVIII) from the endoplasmic reticulum to the Golgi apparatus via an endoplasmic reticulum Golgi intermediate compartment (ERGIC). Mutations in this gene cause combined deficiency of FV and FVIII (F5F8D); a rare autosomal recessive bleeding disorder characterized by mild to moderate bleeding and coordinate reduction in plasma FV and FVIII levels. This protein has also been shown to maintain stem cell potential in adult central nervous system and is a marker for testicular germ cell tumors. The 3' UTR of this gene contains a transposon-like human repeat element named 'THE 1'. A processed RNA pseudogene of this gene is on chromosome 6p22.1. Alternative splicing results in multiple transcript variants encoding distinct isoforms.

Applications:

ELISA, IHC

Name of antibody:

MCFD2

Immunogen:

Fusion protein of human MCFD2

Full name:

multiple coagulation factor deficiency 2

Synonyms:

F5F8D; SDNSF; F5F8D2; LMAN1IP

SwissProt:

Q8NI22

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human cervical cancer

IHC Recommend dilution:

20-100